Alyssum Therap 
Welcome,         Profile    Billing    Logout  
  Products    Diseases   Products    Trials    News 
1 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
AT1965 / Alyssum Therap
NCT06234098: Study to Investigate the Safety, Tolerability, Pharmacokinetics, Pharmocodynamics and Preliminary Antitumor Activity of AT-1965 in Patients With Advanced, Refractory or Recurrent Solid Tumors

Recruiting
1/2
85
US
AT-1965 Liposome Injection
Alyssum Therapeutics, CBCC Global Research
Solid Tumor
12/26
01/27
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
AT1965 / Alyssum Therap
NCT06234098: Study to Investigate the Safety, Tolerability, Pharmacokinetics, Pharmocodynamics and Preliminary Antitumor Activity of AT-1965 in Patients With Advanced, Refractory or Recurrent Solid Tumors

Recruiting
1/2
85
US
AT-1965 Liposome Injection
Alyssum Therapeutics, CBCC Global Research
Solid Tumor
12/26
01/27

Download Options